Partnerships for Enhanced Engagement in Research (PEER) health: a new programme to facilitate LMIC research capacity  by Raulfs-Wang, Callie et al.
Meeting Abstracts
48 www.thelancet.com/lancetgh 
Partnerships for Enhanced Engagement in Research (PEER) 
health: a new programme to facilitate LMIC research capacity
Callie Raulfs-Wang, Cameron Bess, Robert Gasior, Kathleen Handley, James Herrington, Elizabeth Higgs, Vesna Kutlesic, Sybil Phillip, 
Elizabeth Sharp, Annica Wayman
Abstract
Background The Partnership for Enhanced Engagement in Research (PEER) Health programme, funded by the 
United States Agency for International Development (USAID), is a new research partnership programme that 
directly supports researchers from developing countries as Principal Investigators in partnership with collaborators 
at the US National Institutes of Health (NIH). The goals of this programme are threefold: (1) to advance critical 
evidence to address crucial health challenges facing LMICs; (2) to support collaboration and build on existing 
relationships between local public health and research institutions, global health practitioners, host country 
government, NIH researchers, and USAID Missions and Embassy staﬀ ; and (3) to build capacity by supporting 
researchers in LMICs thereby enabling local solutions to context speciﬁ c challenges.
Methods More than 180 preproposals from 25 LMICs were submitted to the ﬁ rst PEER Health research solicitation 
focused on Child Survival. After consultation with USAID Missions to ensure relevance to host country health 
priorities, about 80 applicants were invited to submit a full proposal. The National Institute of Child Health and 
Human Development organised a special emphasis panel for the scientiﬁ c review of PEER Health full proposals to 
address both scientiﬁ c merit and research capacity building aspects of the grant proposals, whilst maintaining key 
elements of the standard NIH peer review model. 40 experienced NIH reviewers, representing a wide variety of 
scientiﬁ c disciplines and global public health experience, did the peer review of grants using a novel IT system 
developed for the PEER Health initiative. The National Academies of Sciences hosted an interagency protocol review 
to ensure scientiﬁ c validity and compliance with international human subject guidelines.
Findings Sixteen diverse grant partnerships were awarded in ten USAID Child Survival priority countries in Africa and 
Asia. Research funded under this programme is varied and includes studies from diverse topical areas, including 
malaria, neonatal sepsis, breast-feeding, tuberculosis, prevention of mother-to-child transmission, among others. 
Studies include investigation of both facility and community level interventions. NIH partners are largely US based and 
half are support by the National Institute of Allergy and Infectious Disease (NIAID).
Interpretation Broad interest in this novel programme and applications from 25 countries show a crucial need for 
more directed funding for research strengthening and partnerships with LMIC Principal Investigators.
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